World first clinical trial commences in alcohol use disorder
Clinical Research | News | 0 Comment | 28 Oct, 2019
A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...Read more
SCRI honors Clinical Research Coordinators by Distinguished Contributor Award 2019
Clinical Research | News | 0 Comment | 22 Oct, 2019
The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...Read more
ASLAN enrolls first patient to study ASLAN004 targeting Atopic Dermatitis
Clinical Research | News | 0 Comment | 22 Oct, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...Read more
Rentschler Biopharma to expand Japanese operation base
Clinical Research | News | 0 Comment | 23 Oct, 2019
Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...Read more
ImaginAb inks pact with three global pharma companies
Clinical Research | News | 0 Comment | 15 Oct, 2019
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...Read more
Thermo Fisher expands clinical trials capabilities in China
Clinical Research | News | 0 Comment | 26 Sep, 2019
Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...Read more
WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study
Clinical Research | News | 0 Comment | 20 Sep, 2019
The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...Read more
Japan's Solasia set to start trials for Darinaparsin
Clinical Research | News | 0 Comment | 20 Sep, 2019
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...Read more
ASLAN presents Ph2 study data for Varlitinib tested on BTC patients
Clinical Research | News | 0 Comment | 19 Sep, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...Read more
Covance unveils new R&D center in Shanghai
Clinical Research | News | 0 Comment | 17 Sep, 2019
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...Read more
Novotech highlights South Korea's plans on clinical trials advancements
Clinical Research | News | 0 Comment | 16 Sep, 2019
Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...Read more
Strekin AG completes patient recruitment in RESTORE Ph3 of STR001
Clinical Research | News | 0 Comment | 15 Sep, 2019
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...Read more
IBI303 results for Ankylosing Spondylitis published in "The Lancet Rheumatology”
Clinical Research | News | 0 Comment | 02 Sep, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...Read more
Ascletis receives IND approval for its NASH drug
Clinical Research | News | 0 Comment | 28 Aug, 2019
Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...Read more
Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019
Clinical Research | News | 0 Comment | 27 Aug, 2019
ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...Read more
First patient dosed for Phase I/II trial of avapritinib in advanced GIST
Clinical Research | News | 0 Comment | 26 Aug, 2019
CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...Read more
New trial to evaluate an investigational drug for Parkinson's disease
Clinical Research | News | 0 Comment | 26 Aug, 2019
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...Read more
CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia
Clinical Research | News | 0 Comment | 23 Aug, 2019
CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...Read more